A R T I C L E S
Bas´ılio Janke et al.
Concentration-dependent chemical shifts were fitted with an appropriate
equation by employing the Marquardt-Levenberg algorithm. Ab initio
calculations were performed using SPARTAN, Version 4.1.1.
0.3) as eluent. The appropriate fractions were combined, and the solvent
was removed to provide 0.91 g (1.166 mmol, 65.3%) of pure product.
1H NMR (250 MHz, CDCl3): δ (ppm) -0.043 (s, 3H, CH3Si), -0.024
(s, 3H, CH3Si), 0.14 (s, 3H, CH3Si), 0.13 (s, 3H, CH3Si), 0.12 (s, 3H,
CH3Si), 0.11 (s, 3H, CH3Si), 0.78 (s, 9H, (CH3)3C), 0.94 (d, 9H
(CH3)3C), 0.95 (d, 9H, (CH3)3C), 3.72 (dd 1H, H5′), 3.91 (dd, 1H, H5′′),
4.08 (q, 1H, H4′), 4.25 (t, 1H, H3′), 4.48 (t, 1H, H2′), 5.29 (d, 2H,
CH2Ph), 5.85 (d, 1H, H1′), 7.30 (m, 5H, Ph), 7.69 (s, 1H, H8), 7.90 (s,
1H, H2).
Materials. Reagents of the highest quality available were purchased
from Sigma-Aldrich, Deisenhofen, Germany. 15NH4Cl was purchased
either from Chemotrade, Leipzig (95% of label), or from Deutero
GmbH, Kastellaun (99% of label). All reactions were controlled by
TLC on silica gel plates (Merck silica gel 60 F254). If necessary, solvents
were dried by standard procedures prior to use. The deuterated Freon
mixture CDClF2/CDF3 was prepared as described7 and handled on a
vacuum line which was also used for the sample preparation. 3′,5′-
Diacetyl-3-15N-2′-deoxythymidine was prepared from unlabeled 2′-
deoxythymidine in analogy to procedures published previously.6b,8 3′,5′-
Di-O-(triisopropylsilyl)-7-15N-2′-deoxyadenosine was synthesized
according to literature procedures9,10 as described.6c
(d) 2′,3′,5′-Tri-O-(tert-butyldimethylsilyl)-6-N-benzyl-1-15N-ad-
enosine. Addition of 63 mL of methanolic dimethylamine (1:1) to 0.96
g (1.230 mmol) of 2′,3′,5′-tri-O-(tert-butyldimethylsilyl)-1-benzyl-6-
15N-adenosine resulted in a two-phase system, which was vigorously
stirred at room temperature for 65 h. The reaction was followed by
TLC on silica gel plates. After completion, the solvent was evaporated,
and the dry residue was purified by chromatography on silica gel using
dichloromethane-methanol (10:0.2) as eluent. The appropriate fractions
were combined to provide after evaporation of the solvent 0.81 g (1.156
mmol, 94%) of pure 2′,3′,5′-tri-O-(tert-butyldimethylsilyl)-6-N-benzyl-
The synthesis of 2′,3′,5′-tri-O-(tert-butyldimethylsilyl)-1-15N-ad-
enosine was performed with some modifications based on a published
procedure.11
(a) 6-15N-Adenosine. After the addition of 0.38 g (6.97 mmol) of
15NH4Cl and 1.05 g (10.48 mmol) of KHCO3 to 1 g (3.49 mmol) of
6-chloroadenosine dissolved in 5 mL of dimethyl sulfoxide, the reaction
mixture was left for 3 days at 80 °C. It was subsequently diluted with
8.8 mL of distilled water, and the pH was adjusted to 7 using
concentrated acetic acid. The solution was evaporated to dryness, and
the product was isolated via column chromatography (SiO2, ethyl
acetate-methanol 1:1). The purification afforded 750 mg (2.79 mmol,
80%) of 6-15N-adenosine. 1H NMR (500 MHz, DMSO): δ (ppm) 3.54
(d, 1H, H5′), 3.65 (d, 1H, H5′′), 3.98 (m, 1H, H4′), 4.15 (m, 2H, OH,
H3′), 4.59 (m, 2H, OH, H2′), 5.88 (d, 1H, H1′), 7.39 (d, 2H, 15NH2),
8.13 (s, 1H, H8), 8.37 (s, 1H, H2).
1
1-15N-adenosine. H NMR (250 MHz, CDCl3): δ (ppm) -0.043 (s,
3H, CH3Si), -0.024 (s, 3H, CH3Si), 0.14 (s, 3H, CH3Si), 0.13 (s, 3H,
CH3Si), 0.12 (s, 3H, CH3Si), 0.11 (s, 3H, CH3Si), 0.78 (s, 9H, (CH3)3C),
0.94 (d, 9H (CH3)3C), 0.95 (d, 9H, (CH3)3C), 3.75 (dd 1H, H5′), 4.01
(dd, 1H, H5′′), 4.11 (q, 1H, H4′), 4.32 (t, 1H, H3′), 4.70 (t, 1H, H2′),
4.87 (d, 2H, CH2Ph), 5.99 (d, 1H, H1′), 6.10 (t, br, NH), 7.32 (m, 5H,
phenyl), 8.05 (s, 1H, H8), 8.37 (d, 1H, H2).
(e) 2′,3′,5′-Tri-O-(tert-butyldimethylsilyl)-1-15N-adenosine. To 0.81
g (1.156 mmol) of 2′,3′,5′-tri-O-(tert-butyldimethylsilyl)-6-N-benzyl-
1-15N-adenosine dissolved in a mixture of 8 mL of dichloromethane, 8
mL of acetonitrile, and 12 mL of distilled water were added 1 g (4.74
mmol) of NaIO4 and 6.77 mg (0.05 mmol) of RuO2‚xH2O. The dark
colored solution was stirred for 23 h at room temperature and filtered.
The filtrate was treated with 50 mL of 6% aqueous sodium hydrogen
carbonate and extracted with three 100 mL portions of dichloromethane.
The organic extracts were combined, concentrated, and treated with
11.6 mL of methanol saturated with ammonia for 37 h. Subsequently,
the solvent was removed and the dry residue was purified by
chromatography on silica gel using dichloromethane-methanol (10:
0.3). The appropriate fractions were pooled and evaporated to dryness
to provide 0.545 g (0.894 mmol, 77%) of crystalline 2′,3′,5′-tri-O-(tert-
butyldimethylsilyl)-1-15N-adenosine. M(C28H55N415NO4Si3) ) 610 g/mol.
1H NMR (250 MHz, CD2Cl2): δ (ppm) -0.043 (s, 3H, CH3Si), -0.024
(s, 3H, CH3Si), 0.14 (s, 3H, CH3Si), 0.13 (s, 3H, CH3Si), 0.12 (s, 3H,
CH3Si), 0.11 (s, 3H, CH3Si), 0.78 (s, 9H, (CH3)3C), 0.94 (d, 9H,
(CH3)3C), 0.95 (d, 9H, (CH3)3C), 3.79 (dd 1H, H5′), 4.01 (dd, 1H, H5′′),
4.11 (q, 1H, H4′), 4.33 (t, 1H, H2′), 4.67 (t, 1H, H2′), 5.73 (br, NH2),
5.99 (d, 1H, H1′), 8.14 (s, 1H, H8), 8.28 (d, 1H, H2).
(b) 2′,3′,5′-Tri-O-(tert-butyldimethylsilyl)-6-15N-adenosine. To a
solution of 0.75 g of 6-15N-adenosine (2.8 mmol) and 1.68 g of
imidazole (24.64 mmol) in 2.8 mL of dry dimethylformamide (DMF)
was added 1.86 g (12.32 mmol) of tert-butyldimethylsilylchlorosilane.
The solution was stirred at room temperature for 20 h under an Ar
atmosphere while being followed by TLC on silica gel plates. After
removal of the solvent under reduced pressure, the syrup-like residue
was dissolved in 50 mL of dichloromethane and mixed with 75 mL of
6% aqueous sodium hydrogen carbonate. The aqueous phase was
extracted with 230-mL portions of CH2Cl2. The combined organic phase
was dried over sodium hydrogen carbonate, filtered, and concentrated
by rotary evaporation to yield a gummy product. This product was
purified by column chromatography (silica gel) using dichloromethane-
methanol (10:0.2) as eluent to provide 1.11 g (1.82 mmol, 65%) of
1
crystalline 2′,3′,5′-tri-O-(tert-butyldimethylsilyl)-6-15N-adenosine. H
NMR (250 MHz, CD2Cl2): δ (ppm) -0.043 (s, 3H, CH3Si), -0.024
(s, 3H, CH3Si), 0.14 (s, 3H, CH3Si), 0.13 (s, 3H, CH3Si), 0.12 (s, 3H,
CH3Si), 0.11 (s, 3H, CH3Si), 0.78 (s, 9H, (CH3)3C), 0.94 (d, 9H
(CH3)3C), 0.95 (d, 9H, (CH3)3C), 3.79 (dd 1H, H5′), 4.01 (dd, 1H, H5′′),
4.11 (q, 1H, H4′), 4.33 (t, 1H, H3′), 4.67 (t, 1H, H2′), 5.69 (d, 15NH2),
5.99 (d, 1H, H1′), 8.15 (s, 1H, H8), 8.3 (s, 1H, H2).
(c) 2′,3′,5′-Tri-O-(tert-butyldimethylsilyl)-1-N-benzyl-6-15N-ad-
enosine. To 1.09 g (1.786 mmol) of 2′,3′,5′-tri-O-(tert-butyldimethyl-
silyl)-6-15N-adenosine dissolved in 11 mL of dry DMF was added 0.42
mL (3.572 mmol) of freshly distilled benzylbromide. The reaction
mixture was stirred at 40 °C for 2 days under an Ar atmosphere. The
solvent was evaporated in vacuo, and the residue was purified by
chromatography on silica gel using dichloromethane-methanol (10:
Results
Low-Temperature Measurements on Adenosine-Acetic
Acid Association. One-dimensional 1H NMR spectra showing
the carboxylic acid OH and adenosine base proton resonances
for a mixture of 3′,5′-di-O-(triisopropylsilyl)-7-15N-2′-deoxy-
adenosine (7A) and acetic acid (HAc) in a Freon solvent are
plotted as a function of temperature in Figure 1. Upon cooling,
the two amino proton signals (broadened at 273 K at around 7
ppm) shift downfield as a result of their increased participation
in hydrogen-bond formation. A significant downfield shift is
also observed for the adenine H8 proton, whereas adenine H2
is slightly upfield shifted at decreasing temperatures. H8 and
H2 protons are easily assigned at higher temperatures because
H8 is split into a doublet due to its scalar coupling 2JNH ) 11.2
Hz with the labeled endocyclic nitrogen-7 of 7A. No resonances
of carboxylic acid OH protons are observed above 193 K, but
(7) Golubev, N. S.; Smirnov, S. N.; Gindin, V. A.; Denisov, G. S.; Benedict,
H.; Limbach, H.-H. J. Am. Chem. Soc. 1994, 116, 12055-12056.
(8) Ariza, X.; Bou, V.; Vilarrasa, J. J. Am. Chem. Soc. 1995, 117, 3665-
3673.
(9) Gaffney, B. L.; Kung, P.-P.; Jones, R. A. J. Am. Chem. Soc. 1990, 112,
6748-6749.
(10) Ogilvie, K. K.; Thompson, E. A.; Quilliam, M. A.; Westmore, J. B.
Tetrahedron Lett. 1974, 33, 2865-2868.
(11) Gao, X.; Jones, R. A. J. Am. Chem. Soc. 1987, 109, 1275-1278.
9
2136 J. AM. CHEM. SOC. VOL. 126, NO. 7, 2004